diabetes

Takeda keeps divestment spree rolling with $1.2B sale of diabetes meds to Japanese firm Teijin
Takeda keeps divestment spree rolling with $1.2B sale of diabetes meds to Japanese firm Teijin
Fierce Pharma
Takeda
diabetes
Teijin Pharma
Flag link:
Patient Centricity in Insulin Delivery: Improving the Injection Experience with Droplet Micron
Patient Centricity in Insulin Delivery: Improving the Injection Experience with Droplet Micron
Xtalks
diabetes
insulin
patients
insulin injection
HTL-STREFA
Droplet Micron needle
Flag link:
Medtronic Gains Momentum in Diabetes
Medtronic Gains Momentum in Diabetes
Medical Devices and Diagnostics Industry
Medtronic
earnings
devices
diabetes
Flag link:
Watch out, Novo Nordisk. Lilly's new dual action diabetes med could pressure Ozempic: analyst
Watch out, Novo Nordisk. Lilly's new dual action diabetes med could pressure Ozempic: analyst
Fierce Pharma
Eli Lilly
tirzepatide
Novo Nordisk
Ozempic
diabetes
Flag link:
CGM, insulin pump players look to 2021 as watershed year for diabetes wearables market
CGM, insulin pump players look to 2021 as watershed year for diabetes wearables market
Medtech Dive
insulin pumps
continuous glucose monitoring
diabetes
Insulet
DexCom
Medtronic
devices
Flag link:
Insulin’s Out-Of-Pocket Cost Burden To Diabetic Patients Continues To Rise Despite Reduced Net Costs To PBMs
Insulin’s Out-Of-Pocket Cost Burden To Diabetic Patients Continues To Rise Despite Reduced Net Costs To PBMs
Forbes
diabetes
insulin
drug pricing
Flag link:
rBIO Launches with Technology to Hyper-Produce Insulin Cost-Effectively, at Scale
rBIO Launches with Technology to Hyper-Produce Insulin Cost-Effectively, at Scale
BioSpace
rBIO
insulin
diabetes
rDNA
drug manufacturing
Flag link:
Lilly's Tirzepatide Significantly Reduced A1C and Body Weight in People with Type 2 Diabetes
Lilly's Tirzepatide Significantly Reduced A1C and Body Weight in People with Type 2 Diabetes
Drugs.com
Eli Lilly
tirzepatide
clinical trials
type 2 diabetes
diabetes
Flag link:
Dexcom takes no-fingerprick message to people with Type 2 diabetes in new TV ads
Dexcom takes no-fingerprick message to people with Type 2 diabetes in new TV ads
Fierce Pharma
DexCom
DTC advertising
diabetes
type 2 diabetes
blood glucose monitoring
Flag link:
Vivek Ramaswamy’s Metavant hits a brick wall, abandoning a lead program for diabetes. And there’s nothing visible left to see here
Vivek Ramaswamy’s Metavant hits a brick wall, abandoning a lead program for diabetes. And there’s nothing visible left to see here
Endpoints
Metavant
diabetes
Vivek Ramaswamy
imeglimin
Flag link:
Medtronic ‘Smartens’ up Diabetes Offerings with Insulin Pen Launch
Medtronic ‘Smartens’ up Diabetes Offerings with Insulin Pen Launch
Medical Devices and Diagnostics Industry
Medtronic
diabetes
smart insulin
insulin pen
continuous glucose monitoring
devices
Flag link:
Novo Nordisk to boost pill-form diabetic drugs with $1.8 billion deal
Novo Nordisk to boost pill-form diabetic drugs with $1.8 billion deal
Reuters
Novo Nordisk
M&A
Emisphere
pill technology
diabetes
Flag link:
Bayer drug shown to slow diabetic kidney disease
Bayer drug shown to slow diabetic kidney disease
NASDAQ
Bayer
clinical trials
diabeteic kidney disease
kidney disease
diabetes
finerenone
Flag link:
Fresenius outlines plans to expand extracorporeal care portfolio to hearts, lungs
Fresenius outlines plans to expand extracorporeal care portfolio to hearts, lungs
Fierce Biotech
diabetes
Fresenius
intensive care
extracorporeal care
dialysis
Flag link:
Trump claims his policies made insulin ‘so cheap, it’s like water.’ But for most people, it costs just as much as before
Trump claims his policies made insulin ‘so cheap, it’s like water.’ But for most people, it costs just as much as before
Stat
diabetes
insulin
drug prices
Donald Trump
2020 Presidential election
Flag link:
Poxel posts phase 3 diabetes data ahead of approval decision
Poxel posts phase 3 diabetes data ahead of approval decision
Fierce Biotech
Poxel
diabetes
clinical trials
imeglimin
Japan
Flag link:
Could MiniMed 770G’s Approval Boost Medtronic’s Position in Diabetes?
Could MiniMed 770G’s Approval Boost Medtronic’s Position in Diabetes?
Medical Devices and Diagnostics Industry
diabetes
Medtronic
MiniMed 770G
insulin pumps
Flag link:
Novo launches type 2 diabetes pill in UK after NICE waives review
Novo launches type 2 diabetes pill in UK after NICE waives review
Pharmaforum
Novo Nordisk
UK
type 2 diabetes
diabetes
Rybelsus
semaglutide
NICE
Flag link:
Biocon and Mylan Launch Semglee; Biosimilar, Interchangeable Status Are Sought
Biocon and Mylan Launch Semglee; Biosimilar, Interchangeable Status Are Sought
Center for Biosimilars
Biocon
Mylan
Semglee
generics
insulin
diabetes
biosimilars
Flag link:
ESC 2020 – Farxiga impresses in chronic kidney disease
ESC 2020 – Farxiga impresses in chronic kidney disease
EP Vantage
ESC
Farxiga
chronic kidney disease
diabetes
clinical trials
AstraZeneca
Flag link:

Pages